FibroBiologics, Inc. (FBLG)
$1.13+1.80%Close
SELLCRISIS · day 23
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $2M
- Beta
- 1.22
- P/E (TTM)
- -0.19
- Short % float
- 32.56%
- Days to cover
- 3.8
- SI change
- -21.1%
- 1W
- -8.87%
- 1M
- -34.68%
- vs SPY 1W
- -10.03%
- vs SPY 1M
- -37.67%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on FBLG?
- LOPJLB’s latest quantitative signal on FibroBiologics, Inc. Common Stock (FBLG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is FBLG in?
- FibroBiologics, Inc. Common Stock (FBLG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does FibroBiologics, Inc. Common Stock (FBLG) do?
- FibroBiologics, Inc. operates as a clinical-stage biopharmaceutical firm, advancing therapies derived from fibroblasts toward commercialization within the United States. The company's pipeline includes CybroCell, currently being developed to address degenerative disc disease; CYMS101, targeting multiple sclerosis; and CYWC628 for wound repair. Further demonstrating its broad scope, early-stage …